ahlam1399
07-02-2016, 03:00 AM
UK ***** regulator to halt approvals for Indian clinical trials firm
MUMBAI (Reuters) - The UK's healthcare regulator has decided to suspended marketing approval for a widely used antibiotic that had won clearance based on clinical trials conducted by India's Quest Life Sciences, due to concerns over the integrity of trial data.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=**xiQeRaGv4:_**eolycXqo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=**xiQeRaGv4:_**eolycXqo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=**xiQeRaGv4:_**eolycXqo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=**xiQeRaGv4:_**eolycXqo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=**xiQeRaGv4:_**eolycXqo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/**xiQeRaGv4
MUMBAI (Reuters) - The UK's healthcare regulator has decided to suspended marketing approval for a widely used antibiotic that had won clearance based on clinical trials conducted by India's Quest Life Sciences, due to concerns over the integrity of trial data.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=**xiQeRaGv4:_**eolycXqo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=**xiQeRaGv4:_**eolycXqo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=**xiQeRaGv4:_**eolycXqo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=**xiQeRaGv4:_**eolycXqo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=**xiQeRaGv4:_**eolycXqo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/**xiQeRaGv4